Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended-Release Naltrexone as Opioid Overdose Pre-Exposure Prophylaxis (PrEP) in People Using Stimulants Living With or At Risk of HIV

NCT06633900 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT06633900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06633900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended-Release Naltrexone as Opioid Overdose Pre-Exposure Prophylaxis (PrEP) in People Using Stimulants Living With or At Risk of HIV
Lead sponsor
University of California, San Francisco
Phase
Phase 2/3
Overall status
Recruiting
Start date
April 10, 2025
Completion date
April 15, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overdose accidental